EcoDrugPlus

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSSAUG00010018747
Gene Symbol: CYSLTR1
3 Cross references
172 Possible Orthologues:

Cytidine Deaminase-Like

Ensembl ID : ENSSAUG00010016904
Gene Symbol: LOC115582517
3 Cross references
200 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSSAUG00010008917
Gene Symbol: LOC115570740
3 Cross references
194 Possible Orthologues:

Cytochrome P450 3a27-Like

Ensembl ID : ENSSAUG00010016331
Gene Symbol: LOC115596228
3 Cross references
535 Possible Orthologues:

Cytochrome P450 3a30-Like

Ensembl ID : ENSSAUG00010004044
Gene Symbol: LOC115579222
3 Cross references
474 Possible Orthologues:

Cytochrome P450 3a40-Like

Ensembl ID : ENSSAUG00010008337
Gene Symbol: LOC115585601
2 Cross references
445 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSSAUG00010009877
Gene Symbol: CYP19A1
1 Cross references
244 Possible Orthologues:

Cytochrome P450, Family 3, Subfamily A, Polypeptide 65

Ensembl ID : ENSSAUG00010003022
Gene Symbol: CYP3A65
1 Cross references
546 Possible Orthologues:

Cytochrome P450, Family 3, Subfamily A, Polypeptide 65

Ensembl ID : ENSSAUG00010004036
Gene Symbol: CYP3A65
1 Cross references
498 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSSAUG00010026418
Gene Symbol: LOC115596984
3 Cross references
214 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSSAUG00010004507
Gene Symbol: LOC115585253
3 Cross references
188 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1-Like

Ensembl ID : ENSSAUG00010004878
Gene Symbol: LOC115568017
3 Cross references
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).